Pembrolizumab combined with induction chemotherapy and radiotherapy has good clinical efficacy in patients with intermediate and advanced lung squamous cell carcinoma

WANG Xinying; LI Jiashu; JIN Weiquan; GU Yuhai

doi:10.12122/j.issn.1674-4500.2022.04.05

Home>Articles>Pembrolizumab combined with induction chemotherapy and radiotherapy has good clinical efficacy in patients with intermediate and advanced lung squamous cell carcinoma

DOI: 10.12122/j.issn.1674-4500.2022.04.05

Pembrolizumab combined with induction chemotherapy and radiotherapy has good clinical efficacy in patients with intermediate and advanced lung squamous cell carcinoma

WANG Xinying

LI Jiashu

JIN Weiquan

GU Yuhai

Machine-generated Keywords：

Publication Date：2022-08-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 486-492 )

Journal of Molecular Imaging

ISTIC

ISSN：1647-4500

Year, Vol.(Issue)：2022,45(4)